I.D. Systems Receives Follow-On Orders from North America Auto Manufacturer
Oct 27, 2016 13:04 pm UTC| Business
WOODCLIFF LAKE, N.J., Oct. 27, 2016 -- I.D. Systems, Inc. (NASDAQ:IDSY), a leading provider of enterprise asset management technology and solutions for the Industrial Internet of Things, has received additional orders...
I.D. Systems Receives Follow-On Orders from North America Auto Manufacturer
Oct 27, 2016 13:04 pm UTC| Business
WOODCLIFF LAKE, N.J., Oct. 27, 2016 -- I.D. Systems, Inc. (NASDAQ:IDSY), a leading provider of enterprise asset management technology and solutions for the Industrial Internet of Things, has received additional orders...
Solera National Bancorp Announces 3Q, Nine Months of 2016 Financial Results
Oct 27, 2016 13:03 pm UTC| Business
LAKEWOOD, Colo., Oct. 27, 2016 -- Solera National Bancorp, Inc. (OTC:SLRK), the holding company for Solera National Bank, a business-focused bank primarily serving theDenver metropolitan area, today reported financial...
Solera National Bancorp Announces 3Q, Nine Months of 2016 Financial Results
Oct 27, 2016 13:03 pm UTC| Business
LAKEWOOD, Colo., Oct. 27, 2016 -- Solera National Bancorp, Inc. (OTC:SLRK), the holding company for Solera National Bank, a business-focused bank primarily serving theDenver metropolitan area, today reported financial...
Hanmi Financial Declares Cash Dividend of $0.19 per Share
Oct 27, 2016 13:03 pm UTC| Business
LOS ANGELES, Oct. 27, 2016 -- Hanmi Financial Corporation (NASDAQ:HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that its Board of Directors declared a cash dividend on its common stock for the...
Oct 27, 2016 13:03 pm UTC| Business
MINNEAPOLIS, Oct. 27, 2016 -- Cachet Financial Solutions, Inc. (OTCQB:CAFN), a leading mobile Fintech provider, has launched for Frederick County Bank (FCB) the co-branded express option for deploying Cachet’s...
Oct 27, 2016 13:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 27, 2016 -- Mateon Therapeutics, Inc. (Nasdaq:MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of orphan oncology indications, today...